3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
11
Neoplasms
2
Mycosis Fungoides
2
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphomatoid Papulosis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
3
Vincristine
2
Prednisone
2
Etoposide
2
Doxorubicin
2
tazemetostat
1
pembrolizumab
1
fludarabine
1
etoposide phosphate
1
duvelisib
1
Prednisolone
1
Melphalan
1
Cytarabine
1
Carmustine
1
Azacitidine
1
10-propargyl-10-deazaaminopterin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Enteropathy-Associated T-Cell Lymphoma
×
Brentuximab Vedotin
×
90 days
×
Clear all
No trials found.